Skip to main content

Series C+ · 2026-11-17 · AI

Isomorphic Labs raises $5.00B

90
AI Score
Amount
$5.00B
Round
Series C+
Lead
Greenoaks, Sequoia Capital
HQ
London, GB
Why it matters: The round shows how much capital AI drug discovery can absorb before any candidate reaches human trials, and it sets Isomorphic's IsoDDE platform against a growing field of rivals.

Isomorphic Labs raised a $5B Series C co-led by Greenoaks and Sequoia, six months after its $2.1B Series B.

Participants:
Andreessen Horowitz (a16z), Alphabet, Thrive Capital, MGX, GV, CapitalG, Temasek, UK Sovereign AI Fund

Deal Dossier PRO

Pro feature
Deal Dossier for Isomorphic Labs

Company, lead and participating investors, founders, and verified public contact channels — sourced, generated on demand.

Generate dossier — Pro
Already Pro? Sign in · See plans

Figures marked company-reported are unaudited. Not investment advice. Request a correction or removal (team@midu.si).

More deals with Greenoaks

Recent AI rounds

Browse all deals in the funding database →

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing